Jakavi 5mg Tablets
The Treatment Of Chronic Idiopathic Myelofibrosis
Anti Cancer Drugs
Price to Buy Jakavi 5mg Tablets form India
Brand Name – Jakavi Tablets
Marketed – Novartis
Active Ingredient(s) – Ruxolitinib
Strength – 5mg
Dosage Form – Tablet
Package Size – 14 Tabs
Package Type – Bottle
Expiry – 1 Year to 2 Years
Indication(s) – used in the treatment of chronic idiopathic myelofibrosis.
Prescription Required – Yes
Note: These Tablets are a prescription drug. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Minimum Order Quantity: 1 Piece(s)
Port of Dispatch: New Delhi, India
Production Capacity: As per your required
Jakavi 5mg tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Ruxolitinib belongs to the group of medications called antineoplastics, or anti-cancer medications. More specifically, it is a protein kinase inhibitor.
It is used to treat people with an enlarged spleen and other symptoms of myelofibrosis, a rare type of blood cancer. It is also used to control the amount of red blood cells in the blood (hematocrit) in people with the condition polycythemia vera who have not responded to other medications.
Each round, white-to-almost-white tablet, with “NVR” debossed on one side and “L5” debossed on the other side, contains 5 mg of ruxolitinib.
Anti Cancer Drugs
JAKAVI 15MG TABLETS Is Mainly Used In the treatment of chronic idiopathic myelofibrosis
JAKAVI 15MG TABLETS contains Ruxolitinib. Jakavi 15 mg Tablet is an anti-cancer medication. It works by stop or slow the spread of cancer cells
The most common side effect of JAKAVI 15MG TABLETS are as under:
- Low blood platelets